ask our doctors

Nephrotic Syndrome

Get the facts on Nephrotic Syndrome treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Nephrotic Syndrome prevention, screening, research, statistics and other Nephrotic Syndrome related topics. We answer all your qestions about Nephrotic Syndrome.

Question: What is the latest treatment system for nephrotic syndrome in children ? What is the latest treatment for the nephrotic syndrome in children ?

Answer: The goals of treatment are to relieve symptoms, prevent complications and delay progressive kidney damage. Treatment of the causative disorder is necessary to control nephrotic syndrome. Treatment may be required for life. Corticosteroid, immunosuppressive, antihypertensive, and diuretic medications may help control symptoms. Antibiotics may be needed to control infections. Angiotensin converting enzyme (ACE) inhibitors may significantly reduce the degree of protein loss in the urine and are therefore frequently prescribed for treatment of nephrotic syndrome. If hypertension occurs, it must be treated vigorously. Treatment of high blood cholesterol and triglyceride levels is also recommended to reduce the risk of atherosclerosis. Dietary limitation of cholesterol and saturated fats may be of little benefit, as the high levels which accompany this condition seem to be the result of overproduction by the liver rather than from excessive fat intake. Medications to reduce cholesterol and triglycerides may be recommended. High-protein diets are of debatable value. In many patients, reducing the amount of protein in the diet produces a decrease in urine protein. In most cases, a moderate-protein diet (1 gram of protein per kilogram of body weight per day) is usually recommended. Sodium (salt) may be restricted to help control swelling. Vitamin D may need to be replaced if nephrotic syndrome is chronic and unresponsive to therapy. Blood thinners may be required to treat or prevent clot formation.


Nephrotic Syndrome News

Questcor posts strong Q4 revenue, shares up

Reuters
31, the company expects to post revenue of $75 million, compared with analysts expectation of $68.2 million, according to Thomson Reuters I/B/E/S. The injectable drug Acthar is approved for the treatment of multiple sclerosis and nephrotic syndrome ...
 

Questcor Set for Stronger 2012

Barron's
11, 2012) Questcor Pharmaceuticals this week provided a fourth-quarter Acthar update above our/consensus views driven by surprisingly strong December in nephrotic syndrome. Questcor's (ticker: QCOR) nephrotic syndrome sales force is doubling, ...
 

Questcor Pharmaceuticals Responds to Questions From Investor Blog

PR Newswire (press release)
Questcor Response: In the fourth quarter ended December 31, 2011, the average number of prescriptions written by physicians treating MS exacerbations with Acthar was approximately 2, and the average for physicians treating nephrotic syndrome with ...
 

Four-year-old fights rare disease

Calgary Herald
Her daughter had a rare condition called Nephrotic Syndrome. As the little girl would understand it: "My kidneys are broken." As treatment progressed, more bad news. Most children with the disease grow out of it and their organs recover.
 

Pontefract and Castleford Express

Couple's toy treat for hospital wards
Pontefract and Castleford Express
 

Insurers Post Profit Gains Since Healthcare Legislation [Orange County ...

Insurance News Net (press release)
Acthar, an injectable gel, is used to treat multiple sclerosis flare-ups, as well as for treating kidney disorder nephrotic syndrome and infantile spasms, a very rare form of epilepsy. The drug maker said it filled between 935 and 950 paid ...
 

Los Angeles Times

Murder knocked off list of top US killers: CDC
Reuters
 

Adult Sickle Cell Disease

Dentistry IQ
The potential complications range from microhematuria to gross hematuria with papillary necrosis, microalbuminuria to frank nephrotic syndrome, recurrent urinary tract infections to pylenophritis, and acute to chronic renal failure.
 

FDA Panel Says Omalizumab Safe in Pediatric Patients

Medscape
Panelist Sheldon L. Kaplan, MD, section head, Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, voted yes but said he thought that 2 cases of nephrotic syndrome in 2100 patients was a safety signal ...
 

TheStreetSweeper Issues Part One of Attack on Questcor Pharmaceuticals (QCOR)

StreetInsider.com (subscription) (blog)
Specially the article highlights that the company said in the past it can market Acthar "on-label" as a treatment for nephrotic syndrome (NS) - the company's most significant growth driver. However, the FDA expressed a far more conservative view, ...